We are live on ! Find out more
DM

Deerfield Management Portfolio holdings

AUM $8.48B
1-Year Est. Return 99.04%
This Fund
S&P 500
This Quarter Est. Return
-8.37%
1 Year Est. Return
+99.04%
3 Year Est. Return
+273.78%
5 Year Est. Return
+280.99%
10 Year Est. Return
+2,168.14%
AUM
$5.28B
AUM Growth
-$1.41B
Cap. Flow
-$1.19B
Cap. Flow %
-22.61%
Top 10 Hldgs %
53.54%
Holding
466
New
23
Increased
24
Reduced
24
Closed
360

Top Buys

Rank Stock Value
1
NAMS icon
NewAmsterdam Pharma
NAMS
+$72.5M
2
LEGN icon
Legend Biotech
LEGN
+$64.3M
3
OSCR icon
Oscar Health
OSCR
+$64.1M
4
DVAX
Dynavax Technologies
DVAX
+$62.6M
5
INDV icon
Indivior Pharmaceuticals
INDV
+$39M

Top Sells

Rank Stock Value
1
NUVL
Nuvalent
NUVL
+$187M
2
KURA icon
Kura Oncology
KURA
+$106M
3
CPRX
Catalyst Pharmaceutical
CPRX
+$66.5M
4
SGRY icon
Surgery Partners
SGRY
+$57.4M
5
NBIX icon
Neurocrine Biosciences
NBIX
+$56.2M

Sector Composition

Rank Sector Weight
1 Healthcare 87.97%
2 Industrials 0.23%
3 Consumer Staples 0.01%
4 Energy 0%
5 Technology 0%
Name Market Value Portfolio Weight Shares or Principal Change
in Stake 		Capital Flow
SIGI icon
376
Selective Insurance
SIGI
$5.76B
– –
-7,742
Closed -$722K
HTO
377
H2O America
HTO
$2.67B
– –
-19,014
Closed -$1.1M
SKYT icon
378
SkyWater Technology
SKYT
$1.5B
– –
-93,357
Closed -$848K
SLM icon
379
SLM Corp
SLM
$4.83B
– –
-32,798
Closed -$750K
SLNO
380
DELISTED
Soleno Therapeutics
SLNO
– –
-6,774
Closed -$342K
SMP icon
381
Standard Motor Products
SMP
$902M
– –
-24,213
Closed -$804K
SMPL icon
382
Simply Good Foods
SMPL
$907M
– –
-25,494
Closed -$886K
SNBR
383
DELISTED
Sleep Number
SNBR
– –
-28,275
Closed -$518K
SNV
384
DELISTED
Synovus
SNV
– –
-7,703
Closed -$343K
SONO icon
385
Sonos
SONO
$2.09B
– –
-32,156
Closed -$395K
SPOK icon
386
Spok Holdings
SPOK
$229M
– –
-38,344
Closed -$577K
SPR
387
DELISTED
Spirit AeroSystems
SPR
– –
-20,923
Closed -$680K
SSNC icon
388
SS&C Technologies
SSNC
$18.9B
– –
-3,704
Closed -$275K
STR
389
DELISTED
Sitio Royalties
STR
– –
-10,072
Closed -$210K
STRA icon
390
Strategic Education
STRA
$1.98B
– –
-8,604
Closed -$796K
STRO icon
391
Sutro Biopharma
STRO
$386M
– –
-35,992
Closed -$1.25M
SUI icon
392
Sun Communities
SUI
$15.8B
– –
-3,486
Closed -$471K
SVC
393
Service Properties Trust
SVC
$1.05B
– –
-17,427
Closed -$397K
SWK icon
394
Stanley Black & Decker
SWK
$14.5B
– –
-7,879
Closed -$868K
SWKS icon
395
Skyworks Solutions
SWKS
$9.2B
– –
-2,268
Closed -$224K
SYNA icon
396
Synaptics
SYNA
$4.05B
– –
-11,099
Closed -$861K
TAP icon
397
Molson Coors Class B
TAP
$8.02B
– –
-8,316
Closed -$478K
TDY icon
398
Teledyne Technologies
TDY
$29.2B
– –
-1,028
Closed -$450K
TECH icon
399
Bio-Techne
TECH
$11.2B
– –
-11,531
Closed -$922K
TFSL icon
400
TFS Financial
TFSL
$5.11B
– –
-64,210
Closed -$826K
14 15
16
17 18

Similar funds

FT
Fiduciary Trust Boston, Massachusetts $8.46B AUM 21.38% 1-Year Est. Return
GRQ
Gardner Russo & Quinn Lancaster, Pennsylvania $8.5B AUM 9.79% 1-Year Est. Return
PCM
Penserra Capital Management Orinda, California $8.52B AUM 37.76% 1-Year Est. Return
VA
Valmark Advisers Akron, Ohio $8.42B AUM 14.36% 1-Year Est. Return
QC
Quadrature Capital London, United Kingdom $8.4B AUM 63.34% 1-Year Est. Return
IC
Icahn Carl Sunny Isles Beach, Florida $8.55B AUM 29.29% 1-Year Est. Return
NW
NewEdge Wealth Pittsburgh, Pennsylvania $8.39B AUM 24.47% 1-Year Est. Return
AAF
Andra AP-fonden Goteborg, Sweden $8.39B AUM 21.19% 1-Year Est. Return

Deerfield Management's Q4 2024 Portfolio in Review

As of Q4 2024, Deerfield Management held 466 positions worth $5.28B, down 21% from $6.69B the previous quarter. Its ten largest holdings account for 54% of the portfolio.

Deerfield Management withdrew a net $1.19B in Q4 2024, closing 360 positions and reducing 24 holdings. Its most notable exit was Kura Oncology, an estimated $106M position sold in full.

By sector, the portfolio is most concentrated in Healthcare at 88% of assets, up from 87% a quarter earlier, followed by Industrials and Consumer Staples.

Against the trend, Deerfield Management opened a new position in Legend Biotech worth $50.5M.

  • Deerfield Management's largest Q4 2024 buy was Legend Biotech: 1,551,718 shares worth $50.5M.
  • Deerfield Management added most to NewAmsterdam Pharma in Q4 2024, an estimated $72.5M increase.
  • Deerfield Management's biggest Q4 2024 reduction was Nuvalent, cutting an estimated $187M.
  • Deerfield Management fully exited Kura Oncology in Q4 2024, selling an estimated $106M.
  • Deerfield Management's ten largest holdings make up 54% of its $5.28B portfolio in Q4 2024.
  • Deerfield Management opened 23 new positions and closed 360 in Q4 2024.
  • Deerfield Management's portfolio value fell 21% quarter-over-quarter to $5.28B.

Based on Deerfield Management's 13F filing for Q4 2024, filed 14 Feb 2025.